Balanced representation learning methods have been applied successfully to counterfactual inference from observational data. However, approaches that account for survival outcomes are relatively limited. Survival data are frequently encountered across diverse medical applications, i.e., drug development, risk profiling, and clinical trials, and such data are also relevant in fields like manufacturing (e.g., for equipment monitoring). When the outcome of interest is a time-to-event, special precautions for handling censored events need to be taken, as ignoring censored outcomes may lead to biased estimates. We propose a theoretically grounded unified framework for counterfactual inference applicable to survival outcomes. Further, we formulate a nonparametric hazard ratio metric for evaluating average and individualized treatment effects. Experimental results on real-world and semi-synthetic datasets, the latter of which we introduce, demonstrate that the proposed approach significantly outperforms competitive alternatives in both survival-outcome prediction and treatment-effect estimation.
翻译:然而,考虑到生存结果的方法相对有限; 生存数据在各种医疗应用中经常遇到,例如药物开发、风险分析和临床试验,这些数据也与制造(例如设备监测)等领域有关; 当关注的结果是时间到活动时,需要采取特殊预防措施处理受审查的事件,因为无视审查的结果可能导致有偏颇的估计; 我们提议了一个基于理论的统一框架,用于对生存结果适用的反实际推断; 此外,我们为评价平均和个别治疗效果制定了非参数危险比率衡量标准; 现实世界和半合成数据集的实验结果(我们介绍后一组数据)表明,拟议的办法大大优于生存结果预测和治疗效果估计的竞争性替代办法。